These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8889358)

  • 1. Clinical trials of recombinant hirudin in acute coronary syndromes.
    Challapalli R; Lefkovits J; Topol EJ
    Coron Artery Dis; 1996 Jun; 7(6):429-37. PubMed ID: 8889358
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial results with hirudin and bivalirudin for acute coronary artery syndromes.
    Bates ER
    Semin Thromb Hemost; 1997; 23(6):575-81. PubMed ID: 9469633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second look at bivalirudin.
    Antman EM; Braunwald E
    Am Heart J; 2001 Dec; 142(6):929-31. PubMed ID: 11717592
    [No Abstract]   [Full Text] [Related]  

  • 4. Hirulog: a direct thrombin inhibitor for management of acute coronary syndromes.
    Maraganore JM; Adelman BA
    Coron Artery Dis; 1996 Jun; 7(6):438-48. PubMed ID: 8889359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Publication policy, informed consent, and the randomized clinical trial.
    Califf RM
    Am Heart J; 2002 Feb; 143(2):187-8. PubMed ID: 11835017
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct thrombin inhibitors.
    Anand S
    Haemostasis; 1999 Dec; 29 Suppl S1():76-8. PubMed ID: 10629409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials of Hirulog in patients undergoing high-risk percutaneous transluminal coronary angioplasty.
    Bittl JA
    Coron Artery Dis; 1996 Jun; 7(6):449-54. PubMed ID: 8889360
    [No Abstract]   [Full Text] [Related]  

  • 8. Another chapter of the antithrombin story has been written..
    Antman EM
    Eur Heart J; 1997 Sep; 18(9):1365-7. PubMed ID: 9458438
    [No Abstract]   [Full Text] [Related]  

  • 9. The search for replacements for unfractionated heparin.
    Antman EM
    Circulation; 2001 May; 103(18):2310-4. PubMed ID: 11342482
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct thrombin inhibitors in acute coronary syndromes.
    Jang IK
    Lancet; 2002 Aug; 360(9331):491-2; author reply 492. PubMed ID: 12241752
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.
    Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators
    N Engl J Med; 1996 Sep; 335(11):775-82. PubMed ID: 8778585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific antithrombins in the context of current treatment for acute coronary syndromes.
    Fox KA
    Eur Heart J; 1999 Nov; 20(21):1519-21. PubMed ID: 10529315
    [No Abstract]   [Full Text] [Related]  

  • 14. Hirudin and thrombosis prophylaxis.
    Turpie AG
    Lancet; 1996 Mar; 347(9002):632-3. PubMed ID: 8596373
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.
    Circulation; 1994 Oct; 90(4):1631-7. PubMed ID: 7923645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.
    Bahit MC; Topol EJ; Califf RM; Armstrong PW; Criger DA; Hasselblad V; Betriu A; Hirsh J; Ardissino D; Granger CB
    J Am Coll Cardiol; 2001 Mar; 37(4):1001-7. PubMed ID: 11263599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hirudin in acute coronary syndromes.
    van de Loo A; Bode C
    Semin Thromb Hemost; 2002 Oct; 28(5):459-66. PubMed ID: 12420242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
    Lincoff AM
    Am Heart J; 2003 Oct; 146(4 Suppl):S23-30. PubMed ID: 14564303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and therapeutic applications of hirudin, a new anticoagulant.
    Glusa E
    Kidney Int Suppl; 1998 Feb; 64():S54-6. PubMed ID: 9475490
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
    Direct Thrombin Inhibitor Trialists' Collaborative Group
    Lancet; 2002 Jan; 359(9303):294-302. PubMed ID: 11830196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.